Millennium Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.4M | Sell |
339,200
-685,600
| -67% | -$65.7M | 0.01% | 1246 |
|
|
2025
Q4 | $98.4M | Buy |
1,024,800
+221,900
| +28% | +$21.6M | 0.04% | 442 |
|
|
2025
Q3 | $76.5M | Sell |
802,900
-853,400
| -52% | -$78.5M | 0.03% | 583 |
|
|
2025
Q2 | $144M | Buy |
1,656,300
+720,400
| +77% | +$61.1M | 0.07% | 258 |
|
|
2025
Q1 | $84.1M | Buy |
935,900
+786,300
| +526% | +$70.4M | 0.04% | 443 |
|
|
2024
Q4 | $12M | Sell |
149,600
-197,700
| -57% | -$17.1M | 0.01% | 2005 |
|
|
2024
Q3 | $31.3M | Buy |
347,300
+197,200
| +131% | +$16.6M | 0.01% | 1165 |
|
|
2024
Q2 | $11.8M | Buy |
150,100
+18,500
| +14% | +$1.52M | 0.01% | 1939 |
|
|
2024
Q1 | $11.5M | Sell |
131,600
-17,100
| -11% | -$1.46M | ﹤0.01% | 2059 |
|
|
2023
Q4 | $12.2M | Sell |
148,700
-284,400
| -66% | -$21.7M | 0.01% | 1992 |
|
|
2023
Q3 | $33.9M | Buy |
433,100
+186,600
| +76% | +$15.6M | 0.02% | 992 |
|
|
2023
Q2 | $21.7M | Sell |
246,500
-79,800
| -24% | -$6.87M | 0.01% | 1310 |
|
|
2023
Q1 | $26.3M | Sell |
326,300
-253,700
| -44% | -$20.7M | 0.02% | 1140 |
|
|
2022
Q4 | $45.1M | Buy |
580,000
+261,400
| +82% | +$21.2M | 0.02% | 820 |
|
|
2022
Q3 | $25.7M | Buy |
318,600
+213,900
| +204% | +$19.2M | 0.02% | 1114 |
|
|
2022
Q2 | $9.4M | Sell |
104,700
-34,400
| -25% | -$3.49M | 0.01% | 2112 |
|
|
2022
Q1 | $15.4M | Sell |
139,100
-89,200
| -39% | -$9.42M | 0.01% | 1652 |
|
|
2021
Q4 | $23.6M | Sell |
228,300
-317,200
| -58% | -$36.7M | 0.01% | 1293 |
|
|
2021
Q3 | $68.4M | Buy |
545,500
+347,000
| +175% | +$44.9M | 0.04% | 482 |
|
|
2021
Q2 | $24.6M | Buy |
198,500
+73,500
| +59% | +$9.23M | 0.02% | 1034 |
|
|
2021
Q1 | $14.8M | Sell |
125,000
-73,400
| -37% | -$8.6M | 0.01% | 1378 |
|
|
2020
Q4 | $23.2M | Sell |
198,400
-41,200
| -17% | -$4.54M | 0.02% | 954 |
|
|
2020
Q3 | $24.9K | Sell |
239,600
-2,400
| -1% | -$241K | 0.03% | 655 |
|
|
2020
Q2 | $22.2M | Sell |
242,000
-252,900
| -51% | -$24.3M | 0.03% | 671 |
|
|
2020
Q1 | $44.6M | Buy |
494,900
+271,800
| +122% | +$28.9M | 0.1% | 180 |
|
|
2019
Q4 | $25.3M | Buy |
223,100
+129,100
| +137% | +$14.2M | 0.03% | 699 |
|
|
2019
Q3 | $10.2M | Buy |
94,000
+49,000
| +109% | +$5.11M | 0.02% | 1269 |
|
|
2019
Q2 | $4.38M | Sell |
45,000
-60,400
| -57% | -$5.51M | 0.01% | 1883 |
|
|
2019
Q1 | $9.6M | Buy |
+105,400
| New | +$9.43M | 0.01% | 1291 |
|
|
2018
Q3 | – | Sell |
-110,000
| Closed | -$9.42M | – | 4131 |
|
|
2018
Q2 | $9.42M | Sell |
110,000
-115,000
| -51% | -$9.61M | 0.01% | 1354 |
|
|
2018
Q1 | $18.1M | Buy |
225,000
+125,000
| +125% | +$10.3M | 0.02% | 934 |
|
|
2017
Q4 | $8.07M | Buy |
100,000
+50,000
| +100% | +$4M | 0.01% | 1471 |
|
|
2017
Q3 | $3.89M | Buy |
50,000
+30,000
| +150% | +$2.49M | 0.01% | 1809 |
|
|
2017
Q2 | $1.77M | Buy |
+20,000
| New | +$1.69M | ﹤0.01% | 2137 |
|
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$3.35M | – | 3633 |
|
|
2015
Q3 | $3.35M | Buy |
+50,000
| New | +$3.68M | 0.01% | 1581 |
|
|
2015
Q1 | – | Sell |
-210,700
| Closed | -$15.2M | – | 3896 |
|
|
2014
Q4 | $15.2M | Buy |
210,700
+110,700
| +111% | +$7.69M | 0.03% | 741 |
|
|
2014
Q3 | $6.2M | Buy |
+100,000
| New | +$6.36M | 0.02% | 1163 |
|
|
2013
Q4 | – | Sell |
-24,900
| Closed | -$1.33M | – | 3632 |
|
|
2013
Q3 | $1.33M | Sell |
24,900
-95,500
| -79% | -$5.14M | ﹤0.01% | 1934 |
|
|
2013
Q2 | $6.2M | Buy |
+120,400
| New | +$5.95M | 0.02% | 892 |
|
Other funds holding MDT
VCM
VPM
Millennium Management's MDT Position: Q1 2026 in Review
Millennium Management reduced its Medtronic (MDT) stake by 84% in Q1 2026, selling an estimated $240M and leaving 472,273 shares worth $40.9M. The position accounts for 0.02% of the portfolio, ranked #982.
Millennium Management first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $560M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Millennium Management held 472,273 shares of Medtronic worth $40.9M as of Q1 2026.
- Millennium Management sold 2,503,215 Medtronic shares in Q1 2026, an estimated $240M.
- Medtronic made up 0.02% of Millennium Management's portfolio in Q1 2026, its #982 holding.
- Millennium Management first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
- Millennium Management's Medtronic position peaked at $560M in Q3 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.